Healing of an ulnar defect using a proprietary TCP bone graft substitute, JAX™, in association with autologous osteogenic cells and growth factors
S.A. Clarke, N.L. Hoskins, G.R. Jordan, D.R. MarshVolume:
40
Year:
2007
Language:
english
Pages:
948
DOI:
10.1016/j.bone.2006.11.004
File:
PDF, 1.17 MB
english, 2007